MCID: PRV003
MIFTS: 38

Perivascular Epithelioid Cell Tumor

Categories: Cancer diseases, Cardiovascular diseases

Aliases & Classifications for Perivascular Epithelioid Cell Tumor

MalaCards integrated aliases for Perivascular Epithelioid Cell Tumor:

Name: Perivascular Epithelioid Cell Tumor 12 15
Perivascular Epithelioid Cell Neoplasms 44 73
Neoplasm with Perivascular Epithelioid Cell Differentiation 12
Pecoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2643
MeSH 44 D054973
NCIt 50 C38150
UMLS 73 C1300127

Summaries for Perivascular Epithelioid Cell Tumor

MalaCards based summary : Perivascular Epithelioid Cell Tumor, also known as perivascular epithelioid cell neoplasms, is related to lymphangioleiomyomatosis and epithelioid sarcoma. An important gene associated with Perivascular Epithelioid Cell Tumor is TSC2 (TSC Complex Subunit 2), and among its related pathways/superpathways are Cytoskeletal Signaling and Aurora B signaling. The drugs Everolimus and Sirolimus have been mentioned in the context of this disorder. Affiliated tissues include liver, uterus and colon, and related phenotypes are cardiovascular system and muscle

Related Diseases for Perivascular Epithelioid Cell Tumor

Diseases related to Perivascular Epithelioid Cell Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 271)
# Related Disease Score Top Affiliating Genes
1 lymphangioleiomyomatosis 30.4 DES PGR TSC2
2 epithelioid sarcoma 30.3 MUC1 VIM
3 pneumothorax 30.2 MUC1 PGR
4 tuberous sclerosis 30.2 SYP TSC2 VIM
5 granular cell tumor 30.1 DES VIM
6 proximal spinal muscular atrophy 30.1 DES MUC1
7 alveolar soft part sarcoma 30.1 DES SYP VIM
8 angiosarcoma 30.0 KIT MUC1 VIM
9 angiomyolipoma 30.0 ACTC1 DES KIT PGR TSC2
10 rhabdomyosarcoma 29.8 ACTC1 DES VIM
11 gastrointestinal stromal tumor 29.8 ACTC1 DES KIT SYP VIM
12 adenomyosis 29.7 MME PGR
13 giant cell tumor 29.7 ACTC1 DES MUC1 VIM
14 fibromatosis 29.6 ACTC1 DES KIT VIM
15 leiomyosarcoma 29.3 ACTC1 DES KIT PGR VIM
16 leiomyoma 29.1 ACTC1 DES KIT MME PGR VIM
17 renal cell carcinoma, nonpapillary 29.0 KIT MME MUC1 TSC2 VIM
18 uterus perivascular epithelioid cell tumor 12.6
19 familial isolated dilated cardiomyopathy 10.3 ACTC1 DES
20 dedifferentiated liposarcoma 10.3 ACTC1 DES
21 myoepithelioma 10.3 ACTC1 VIM
22 lymphangioma 10.2 ACTC1 VIM
23 plasmablastic lymphoma 10.2 DES MUC1
24 osteofibrous dysplasia 10.2 MUC1 VIM
25 fibroblastic rheumatism 10.2 ACTC1 DES
26 mucinous cystadenocarcinoma 10.2 MUC1 VIM
27 chondroid chordoma 10.2 MUC1 VIM
28 lymphangiectasis 10.2 ACTC1 VIM
29 botryoid rhabdomyosarcoma 10.2 ACTC1 DES
30 pericardial mesothelioma 10.2 MUC1 VIM
31 glomangiomyoma 10.2 ACTC1 VIM
32 intravascular papillary endothelial hyperplasia 10.2 ACTC1 VIM
33 infantile digital fibromatosis 10.2 DES VIM
34 glomangioma 10.2 ACTC1 DES
35 necrotizing sialometaplasia 10.2 ACTC1 KIT
36 primitive neuroectodermal tumor of the cervix uteri 10.2 DES VIM
37 hidradenoma 10.2 MUC1 VIM
38 binswanger's disease 10.2 ACTC1 SYP
39 medullomyoblastoma 10.2 DES SYP
40 pulmonary blastoma 10.2 DES SYP
41 malignant mesenchymoma 10.2 DES KIT
42 spindle cell thymoma 10.2 DES MUC1
43 amelanotic melanoma 10.2 KIT VIM
44 fibrolamellar carcinoma 10.2 SYP VIM
45 malignant peritoneal mesothelioma 10.2 MUC1 VIM
46 papilloma of choroid plexus 10.2 MUC1 SYP
47 mucinous ovarian cystadenoma 10.2 MUC1 SYP
48 dysgerminoma 10.2 KIT MUC1
49 adenosquamous carcinoma 10.2 KIT MUC1
50 gastric cardia carcinoma 10.2 KIT MUC1

Graphical network of the top 20 diseases related to Perivascular Epithelioid Cell Tumor:



Diseases related to Perivascular Epithelioid Cell Tumor

Symptoms & Phenotypes for Perivascular Epithelioid Cell Tumor

MGI Mouse Phenotypes related to Perivascular Epithelioid Cell Tumor:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.43 ACTC1 DES KIT PGR TSC2 VIM
2 muscle MP:0005369 9.02 ACTC1 DES KIT PGR VIM

Drugs & Therapeutics for Perivascular Epithelioid Cell Tumor

Drugs for Perivascular Epithelioid Cell Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 98)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
2
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 46835353 6436030 5284616
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
4
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
5 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1
6 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
7 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
10 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
11 Antiparasitic Agents Phase 4,Phase 1
12 Antiprotozoal Agents Phase 4,Phase 1
13 Antimalarials Phase 4,Phase 1
14
Trabectedin Approved, Investigational Phase 3 114899-77-3 108150
15
Doxorubicin Approved, Investigational Phase 3,Phase 2 23214-92-8 31703
16
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 6055-19-2, 50-18-0 2907
17
Mechlorethamine Approved, Investigational Phase 2, Phase 3 51-75-2 4033
18
Ifosfamide Approved Phase 2, Phase 3 3778-73-2 3690
19
Doxil Approved June 1999 Phase 3,Phase 2 31703
20 Alkylating Agents Phase 3,Phase 2
21 Antineoplastic Agents, Alkylating Phase 3,Phase 2
22
Isophosphamide mustard Phase 2, Phase 3 0
23 Topoisomerase Inhibitors Phase 2, Phase 3
24
Propranolol Approved, Investigational Phase 2 525-66-6 4946
25
Letrozole Approved, Investigational Phase 2 112809-51-5 3902
26
Somatostatin Approved, Investigational Phase 2 51110-01-1, 38916-34-6 53481605
27
Octreotide Approved, Investigational Phase 2 83150-76-9 383414 6400441
28
Resveratrol Approved, Experimental, Investigational Phase 2 501-36-0 445154
29
Nintedanib Approved Phase 2 656247-17-5 56843413
30
Celecoxib Approved, Investigational Phase 2 169590-42-5 2662
31
Simvastatin Approved Phase 1, Phase 2 79902-63-9 54454
32
Saracatinib Investigational Phase 2,Phase 1 379231-04-6
33 Vasodilator Agents Phase 2
34 Anti-Arrhythmia Agents Phase 2
35 Antihypertensive Agents Phase 2
36 Angiogenesis Inhibitors Phase 2,Phase 1
37 Adrenergic Antagonists Phase 2
38 Adrenergic beta-Antagonists Phase 2
39 Neurotransmitter Agents Phase 2,Phase 1
40 Adrenergic Agents Phase 2,Phase 1
41 Hormone Antagonists Phase 2
42 Aromatase Inhibitors Phase 2
43 Estrogen Receptor Antagonists Phase 2
44 Steroid Synthesis Inhibitors Phase 2
45 Estrogen Antagonists Phase 2
46 Estrogens Phase 2
47 Hormones Phase 2
48 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
49 Antineoplastic Agents, Hormonal Phase 2
50 Gastrointestinal Agents Phase 2

Interventional clinical trials:

(show all 48)
# Name Status NCT ID Phase Drugs
1 Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis Completed NCT01217125 Phase 4 Sirolimus
2 Doxycycline In Lymphangioleiomyomatosis (LAM) Completed NCT00989742 Phase 4 Doxycycline;Placebo
3 Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. Recruiting NCT03525834 Phase 4 everolimus
4 Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM) Unknown status NCT00414648 Phase 3 Sirolimus;Placebo sirolimus
5 Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00790400 Phase 3 Everolimus (RAD001);Everolimus Placebo
6 Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial Recruiting NCT03150914 Phase 3 Sirolimus
7 Trabectedin Maintenance Post 1st-line in STS Active, not recruiting NCT02929394 Phase 3 Trabectedin
8 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Suspended NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
9 Sirolimus in Treating Patients With Angiomyolipoma of the Kidney Unknown status NCT00126672 Phase 2 sirolimus
10 Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM Unknown status NCT00490789 Phase 2 sirolimus
11 Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers Completed NCT02104011 Phase 2 Propranolol
12 Trial of Aromatase Inhibition in Lymphangioleiomyomatosis Completed NCT01353209 Phase 2 Letrozole;Placebo
13 A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis Completed NCT01059318 Phase 2 Everolimus;Everolimus;Everolimus
14 Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00792766 Phase 1, Phase 2 everolimus (RAD001)
15 RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM Completed NCT00457964 Phase 1, Phase 2 RAD001
16 Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM Completed NCT00457808 Phase 2 Rapamycin, sirolimus
17 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Completed NCT00005906 Phase 2 Octreotide
18 A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa Recruiting NCT02494570 Phase 2 ABI-009
19 Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial Recruiting NCT03253913 Phase 2 Sirolimus;Resveratrol
20 LAM Pilot Study With Imatinib Mesylate Recruiting NCT03131999 Phase 1, Phase 2 Imatinib Mesylate 400Mg Capsule;Placebo - Capsule
21 A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) Recruiting NCT03062943 Phase 2 Nintedanib
22 Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis Recruiting NCT02737202 Phase 2 saracatinib
23 COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC Active, not recruiting NCT02484664 Phase 2 Celecoxib
24 Safety of Simvastatin in LAM and TSC Active, not recruiting NCT02061397 Phase 1, Phase 2 Simvastatin
25 Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Terminated NCT02539459 Phase 2 Everolimus
26 A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Withdrawn NCT01690871 Phase 2 BEZ235
27 The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) Completed NCT02116712 Phase 1 Saracatinib
28 Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis Completed NCT01687179 Phase 1 "Sirolimus" and "Hydroxychloroquine" 200 mg;"Sirolimus" and "Hydroxychloroquine" 400 mg
29 Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis Recruiting NCT01799538 Phase 1 albuterol inhaler;albuterol nebulizer
30 Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease Recruiting NCT01552434 Phase 1 Temsirolimus;Valproic Acid
31 Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors Completed NCT02334930
32 Pulmonary Rehabilitation in Lymphangioleiomyomatosis Completed NCT02009241 Not Applicable
33 The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients Completed NCT02859194 Not Applicable
34 Pulmonary Hypertension in Lymphangioleiomyomatosis Completed NCT00960895
35 Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women Completed NCT00552955
36 Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases Completed NCT00366509
37 Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM) Completed NCT00001869
38 Lymphangioleiomyomatosis (LAM) Registry Completed NCT00005486
39 Discovery of Sirolimus Sensitive Biomarkers in Blood Recruiting NCT03304678
40 A National Registry on Chinese Patients With Lymphangioleiomyomatosis Recruiting NCT03193892
41 EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications Recruiting NCT03477149 Not Applicable
42 Safety and Durability of Sirolimus for Treatment of LAM Recruiting NCT02432560 Sirolimus;Everolimus
43 Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France Recruiting NCT02887781
44 Lymphatic Anomalies Registry Recruiting NCT02399527
45 Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Recruiting NCT02325505
46 National Lymphangioleiomyomatosis Registry, France Recruiting NCT01484236
47 Study of the Disease Process of Lymphangioleiomyomatosis Recruiting NCT00001465
48 Expanded Access for ABI-009 in Patients With Advanced Perivascular Epithelioid Cell Tumors (PEComa) and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation Available NCT03817515 ABI-009

Search NIH Clinical Center for Perivascular Epithelioid Cell Tumor

Cochrane evidence based reviews: perivascular epithelioid cell neoplasms

Genetic Tests for Perivascular Epithelioid Cell Tumor

Anatomical Context for Perivascular Epithelioid Cell Tumor

MalaCards organs/tissues related to Perivascular Epithelioid Cell Tumor:

41
Liver, Uterus, Colon, Cervix, Lung, Kidney, Pancreas

Publications for Perivascular Epithelioid Cell Tumor

Articles related to Perivascular Epithelioid Cell Tumor:

(show top 50) (show all 206)
# Title Authors Year
1
A rare case of perivascular epithelioid cell tumor (PEComa) of the greater omentum. ( 29921303 )
2018
2
Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis: case report. ( 29340502 )
2018
3
Hepatobiliary and Pancreatic: Malignant pancreatic perivascular epithelioid cell tumor mimicking pancreatic neuroendocrine tumor. ( 29888489 )
2018
4
Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor: a case report and literature review. ( 29668485 )
2018
5
Primary pancreatic perivascular epithelioid cell tumor (PEComa): A surgical enigma. A systematic review of the literature. ( 29478828 )
2018
6
Liver perivascular epithelioid cell tumor in a patient with systemic lupus erythematosus. ( 30412918 )
2018
7
An Inguinal Perivascular Epithelioid Cell Tumor Metastatic to the Orbit. ( 30002939 )
2018
8
Successful management of perivascular epithelioid cell tumor of the rectum with recurrent liver metastases: A case report. ( 30075560 )
2018
9
Hepatic perivascular epithelioid cell tumor: A case report. ( 30140716 )
2018
10
TFE3-Expressing Perivascular Epithelioid Cell Tumor of the Breast. ( 30269476 )
2018
11
Perivascular Epithelioid Cell Tumor of the Liver. ( 30269733 )
2018
12
Giant Perivascular Epithelioid Cell Tumor of the Orbit: A Clinicopathological Analysis and Review of the Literature. ( 30320097 )
2018
13
Perivascular epithelioid cell tumor outgrowth from the liver. ( 30453241 )
2018
14
Perivascular Epithelioid Cell Tumor of the Liver. ( 30454524 )
2018
15
Presence of eosinophilic intracytoplasmic inclusions diagnosed by fine needle aspiration cytology in perivascular epithelioid cell tumor (PEComa) arising from the cecum. ( 30499191 )
2018
16
Perirenal perivascular epithelioid cell tumor (PEComa) coexisting with other malignancies: a case report. ( 28547987 )
2017
17
Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature. ( 29208563 )
2017
18
Malignant perivascular epithelioid cell tumor of the orbit: Report of a case and review of literature. ( 28905842 )
2017
19
Cardiac Perivascular Epithelioid Cell Tumor. ( 28415905 )
2017
20
Two cases of perivascular epithelioid cell tumor of the uterus: clinical, radiological and pathological diagnostic challenge. ( 28270196 )
2017
21
Liver Perivascular Epithelioid Cell Tumor with an Unusual Location: Diagnostic Characteristics with Multidetector Computed Tomography and Magnetic Resonance Imaging. ( 28975043 )
2017
22
Case of lymph node primary perivascular epithelioid cell tumor associated with leukoderma. ( 28868802 )
2017
23
An orbital perivascular epithelioid cell tumor in a 7-year-old boy: case report and review of the literature. ( 28576480 )
2017
24
Computed tomography imaging features of hepatic perivascular epithelioid cell tumor: A case report and literature review. ( 29245304 )
2017
25
Primary cutaneous perivascular epithelioid cell tumor (PEComa): Five new cases and review of the literature. ( 28556973 )
2017
26
Perivascular Epithelioid Cell Tumor (PEComa) of the Uterine Cervix: A Case Report of a 43-Yr-Old Woman With Abnormal Uterine Bleeding Treated With Hysterectomy. ( 28787320 )
2017
27
Perivascular Epithelioid Cell Tumor in the Stomach. ( 28372349 )
2017
28
Pneumothorax caused by cystic and nodular lung metastases from a malignant uterine perivascular epithelioid cell tumor (PEComa). ( 28706850 )
2017
29
Hepatic perivascular epithelioid cell tumor treated by transarterial embolization plus radiofrequency ablation: A case report and literature review. ( 28562547 )
2017
30
Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures. ( 28288506 )
2017
31
Broad Ligament Perivascular Epithelioid Cell Tumor (PEComa) of Uncertain Malignant Potential. ( 26832182 )
2016
32
Perivascular epithelioid cell tumor of the ileum. A case report. ( 26900883 )
2016
33
Pigmented perivascular epithelioid cell tumor (PEComa) arising from kidney: A case report. ( 27858882 )
2016
34
Hepatic perivascular epithelioid cell tumor: Case report and brief literature review. ( 28002331 )
2016
35
Hepatic perivascular epithelioid cell tumor in three patients. ( 27919857 )
2016
36
Cutaneous Perivascular Epithelioid Cell Tumor of Gynecologic Origin Metastatic to Skin, Lung, Stomach, and Brain. ( 27149334 )
2016
37
Perivascular Epithelioid Cell Tumor (PEComa) of Pancreas Diagnosed Preoperatively by Endoscopic Ultrasound-Guided Fine-Needle Aspiration: A Case Report and Review of Literature. ( 27628738 )
2016
38
Intrahepatic peribiliary perivascular epithelioid cell tumor (PEComa) associated with heterotopic pancreas: A case report. ( 27542598 )
2016
39
Sclerosing Perivascular Epithelioid Cell Tumor of the Lung: A Case Report with Cytologic Findings. ( 27068025 )
2016
40
Primary Perivascular Epithelioid Cell Tumor (PEComa) of the Bladder: A Case Report With 2-Years of Follow-Up and Review of Current Literature. ( 27793610 )
2016
41
Perivascular epithelioid cell tumor of the descending colon mimicking a gastrointestinal stromal tumor: a case report. ( 27842558 )
2016
42
Pancreatic perivascular epithelioid cell tumor: A case report with clinicopathological features and a literature review. ( 27053862 )
2016
43
A systematic review: perivascular epithelioid cell tumor of gastrointestinal tract. ( 27428182 )
2016
44
Perivascular epithelioid cell tumor of the uterus: Report of two cases and mini-review of the literature. ( 27689526 )
2016
45
WITHDRAWN: A Unique Case of Perivascular Epithelioid Cell Tumor Associated With Birt-Hogg-Dube Syndrome. ( 29079164 )
2016
46
Perivascular Epithelioid Cell Tumor of the Uterus with Ovarian Involvement: A Case Report and Review of the Literature. ( 27150246 )
2016
47
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature. ( 27793946 )
2016
48
Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review. ( 28105182 )
2016
49
Pigmented Perivascular Epithelioid Cell Tumor of the Skin: First Case Report. ( 26355762 )
2015
50
Perivascular Epithelioid Cell Tumor of the Liver. ( 26601751 )
2015

Variations for Perivascular Epithelioid Cell Tumor

Expression for Perivascular Epithelioid Cell Tumor

Search GEO for disease gene expression data for Perivascular Epithelioid Cell Tumor.

Pathways for Perivascular Epithelioid Cell Tumor

Pathways related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.75 ACTC1 DES MUC1 VIM
2
Show member pathways
10.81 DES VIM
3 10.66 ACTC1 DES VIM

GO Terms for Perivascular Epithelioid Cell Tumor

Cellular components related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytoplasm GO:0005737 9.56 ACTC1 DES KIT MME MUC1 PGR
2 neuron projection terminus GO:0044306 8.62 MME SYP

Biological processes related to Perivascular Epithelioid Cell Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.33 KIT MUC1 VIM
2 intermediate filament organization GO:0045109 8.96 DES VIM
3 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Sources for Perivascular Epithelioid Cell Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....